In this Section |
265607 Bad health and retirement: A new approach using genetic materialSunday, October 28, 2012
Understanding the role of bad health on retirement decisions presents challenges to researchers due to the inherent endogeneity between health and labor market participation. I exploit the fact that an individual's genotypes are assigned randomly from parent to offspring and are therefore plausibly exogenous to use a genotype as an instrumental variable. I use Apolipoprotein E, a gene that has been associated with variations in cognitive change started at mid-age and has been clinically linked to Alzheimer's disease. Given that genes are randomly assigned and people rarely know their own genotypes, this gene is a valid instrument in that it is correlated with the potentially endogenous variable (cognitive decline) and unrelated to unobserved determinants of the outcome variable (retirement). I consider people's retirement decisions in light of either experiencing cognitive decline or not. The overall equation is: PR(retired)I = α + β1 HEALTHi + β2 WEALTHi + β3 Zi + ε i With a first-stage equation: HEALTHi = GenIVi Θ + νi I use the Health and Retirement Survey (HRS), which includes key SES and labor market outcomes including wealth, income, and retirement decisions, along with tests of several salient dimensions of cognitive skills. The longitudinal nature of this survey will allow me to track cognitive changes over time. The HRS will soon release genetic data for a subsample of HRS respondents, and I have gained access to this restricted data, which will allow me to jointly consider both phenotypic and genotypic information for a sample of approximately 20,000 respondents.
Learning Areas:
Social and behavioral sciencesLearning Objectives: Keywords: Decision-Making, Dementia
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I have an MA in Demography and an MA in Economics and am a PhD candidate in Demography at UC Berkeley. I have been working with the data for years and have developed expertise in aging. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 2032.0: Alzheimer's Disease, Dementia, and Related Issues
|